Entrar/Registro  
HOME SPANISH
 
Ginecología y Obstetricia de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Ginecología y Obstetricia de México >Year 2011, Issue 12


Navarro-Meza M, Martínez-Rivera MG, Santoyo-Telles F, Pita-López ML
Glucose, body mass index and pre-neoplastic lesions in the cervix
Ginecol Obstet Mex 2011; 79 (12)

Language: Español
References: 20
Page: 771-778
PDF: 250.47 Kb.


Full text




ABSTRACT

Background: The obesity and abnormal blood glucose level has been associated with cervical cancer development; however, few studies have been performed about this relation.
Objective: Evaluate the blood glucose levels and body mass index (BMI) in women with human papilloma virus infection (HPV-I) and cervical intraepithelial neoplasia (CIN-I).
Patients and method: Transversal study of 44 women diagnosed with HPV-I and CIN-I from September to December 2010 in Dysplasia Clinic of Regional Hospital of Guzman City, Federal entity of Jalisco, Mexico. The diagnoses were carried by biopsy of cervix, glucose test results were evaluated by spectrophotometry and determinate the BMI.
Results: The 18% (n=8) of women were without injury, 41% (n=18), with HPV-I and 41% (n=18) CIN-I. High blood glucose was observed in CIN-I versus without injury in the cervix (p = 0.05), the correlation was OR = 2.6 (95% CI: 1.090-6.52). The young women (19-35 years) were 17% high glucose, 28% normal glucose and 55% low glucose. In group of the medium age (35-65 years) 23% showed high glucose, 50% normal and 27% low. The BMI was not relation with diagnosis, although in the age (young versus age median p=0.001).
Conclusion: These results support the proposal about the high levels of glucose in plasma and obesity could be risk cofactors in the development of preneoplasic lesion of cervix.


Key words: Glucose, Body Mass Index, BMI, Preneoplasic lesions, Cervix.


REFERENCIAS

  1. Secretaría de Salud Jalisco. 2010. http://www.jalisco.gob.mx/wps/portal/sriaSalud/

  2. Stanley M. Pathology and epidemiology of HPV infection infemales. Gynecol Oncol 2010;117:S5-10.

  3. Schlect NF, Kulaga S, Robitaille J. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-3114.

  4. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females. J Adolesc Health 2008;43:5-25.

  5. De San José S, Diaz M, Castellsagué X, Clifford G, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7:453-459.

  6. Ergünay K, Misirlioglu M, Firat P, Tuncer ZS, et al. Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities. Microbylogi butei 2008;2:273-282.

  7. Muñoz N, Castellsague X, Berrington de González A, Gissman L. El VPH en la etiología del cáncer humano. Vaccine 2006;24S3:3-10.

  8. Pérez-Guisado J. Carbohydrates, glucose metabolism and cancer. Endocrinol Nutr 2006;53:252-255.

  9. Annibaldi A, Widmann C. Glucose metabolism in cancer cells. 2010;4:466-470

  10. Renehan A, Zwahlen M, Minder C, Shalet S, Egger M. Insulinlike growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;9418:1346-1353.

  11. Amaral P, Miguel R, Mehdad A, Cruz C, et al. Body fat and poor diet in breast cancer women. Nutr Hosp 2010;3:456-461.

  12. Aranceta BJ. Nutrición Comunitaria. En: Nutrición y dietética clínica. Madrid: Masson, 2001;75-87.

  13. Finucane MM, Stevens GA, Cowan MJ, Danaei G, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;9765:557-567.

  14. Simões NR, Lima-Neto AS, Capuci-Kalebe A, Tavares-Murta BM, et al. Relationship between plasma glucose levels and malignant uterine cervical neoplasias. Clin Med Insights Oncol 2011;5:77-82.

  15. García CR, Castellsagué X, Bosch X, González CA. The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence Cancer Epidemiology and Registration Unit, Institut Català d’ Oncologia (ICO), L’ Hospitalet de Llobregat. Barcelona, 2005;117, 629-637.

  16. Augustin LS, Gallus S, Bosetti C, Levi F, et al. Glycemic index and glycemic load in endometrial cancer. FALTA 2003;3:404-407.

  17. Stocks T, Rapp K, Bjørge T, Manjer J, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. FALTA 2009;12:e1000201.

  18. Jee SH, Ohrr H, Sull JW, Yun JE, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;2:194-202.

  19. Osuna-Ramírez I, Hernández-Prado B, Campuzano JC, Salmerón J. Body mass index and body image perception in a Mexican adult population: the accuracy of self reporting. Salud Pública Mex 2006;2:94-103.

  20. Soto Monge T, Lagos Sánchez E. Obesidad y cáncer: un enfoque epidemiológico, salud pública. Revista Médica de Costa Rica y Centroamérica 2009;19(587):27-32.






>Journals >Ginecología y Obstetricia de México >Year 2011, Issue 12
 

· Journal Index 
· Links 






       
Copyright 2019